References
- D'Oleire F., Robins H. I., Cohen J. D., Schmitt C. L., Spriggs D. Cytokine induction in humans by 41.8°C whole body in hyperthermia. Journal of the National Cancer Institute 1993; 85: 833–834
- Haveman J., Geerdink A. G., Rodermond H. M. Cytokine production after whole body and localized hyperthermia. International Journal Hyperthermia 1996; 12: 791–800
- Ibelgaufts H. Dictonary of cytokines. F. Hoffmann-La Roche, Basel 1995; 368
- Katschinski D. M., Wiedemann G. J., Mentzel M., Longo W., D'Oleire F., Grosen E. A., Mulkerin D., Kutz M. E., Robins H. I. Implications of 41.8°C whole body hyperthermia cytokine induction to cytotoxic therapy and bone marrow transplantation. Proceedings of the AACR 1997; 38, abst. in press
- Robins H. I., Cohen J. D., Schmitt C. L., Tutsch K. D., Feierabend, Arzoomanian C. R. Z., Alberti D., D'Oleire F., Longo W., Heiss C., Rushing D., Spriggs D. Phase I clinical trial of carboplatin and 41.8°C whole body hyperthermia in cancer patients. Journal of Clinical Oncology 1993; 11: 1787–1794
- Robins H. I., Dennis W. H., Steeves R. A., Sondel P. M. A proposal for the addition of hyperthermia to treatment regimens for acute and chronic leukemia. Journal of Clinical Oncology 1984; 2: 1050–1056
- Robins H., Kutz M., Tutsch K., Tiggelaar C., Paul D., Longo W., D'Oleire F. Phase I clinical trial of melphalan (L-PAM) and 41.8°C whole body hyperthermia (WBH) in cancer patients. Journal of Clinical Oncology 1997; 15: 158–164
- Robins H. L., Kutz M., Wiedemann G., Paul D., Katschinski D. M., Grosen E., Tiggelaar C. L., Spriggs D., Gillis W., D'Oleire F. Cytokine induction by 41.8°C whole body hyperthermia. Cancer Letter 1995; 97: 195–201